Patient
SITE001-0057
enrolled Phase IIIA Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · SITE001 (USA) (Dr. Reyes)
consented 2025-10-30
Adverse events
4
Serious AEs
1
Open data queries
0
Luna dropout signal
+0.4
Adverse events 4
Grade 1 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2023-02-07 (study day 270); relationship: not assessed
Grade 3 Alopecia — outcome: RECOVERED/RESOLVED; onset 2023-01-18 (study day 250); relationship: NOT RELATED; serious criteria: hospitalization
Grade 2 Decreased appetite — outcome: RECOVERED/RESOLVED; onset 2022-08-23 (study day 102); relationship: not assessed
Grade 2 Stomatitis — outcome: RECOVERED/RESOLVED; onset 2022-08-18 (study day 97); relationship: not assessed
Data queries 0
No data queries
The CDM sweep raises queries on inconsistent fields.
Luna engagement
Messages
2
Escalations
2
Check-ins
2
last 2026-09-19
Mood ø
2.0
of 5
Adherence · 7d
0%